Effect of KIT Inhibition by Imatinib on Airway Mast Cells in Patients with Severe Refractory Asthma (KIA) - 19/04/17
Doi : 10.1016/j.jaci.2016.12.553
Katherine N. Cahill, MD 1, Howard Katz, PhD 2, Jing Cui 3, Juying Lai 3, Shamsah Kazani, MD 4, Allison Crosby-Thompson 3, Denise Garofalo 1, Mario Castro, MD 5, Nizar N. Jarjour, MD 6, Emily DiMango, MD 7, Serpil C. Erzurum 8, Jennifer L. Trevor 9, Kartik Shenoy, MD 10, Vernon M. Chinchilli, PhD 11, Michael E. Wechsler, MD 12, Tanya M. Laidlaw, MD, FAAAAI 1, Elliot Israel, MD, FAAAAI 3, Joshua A. Boyce, MD, FAAAAI 13
1 Brigham and Women's Hospital, Division of Rheumatology, Immunology and Allergy, Boston, MA
2 Brigham & Women's Hospital, Boston, MA
3 Brigham and Women's Hospital, Boston, MA
4 Novartis Institutes for BioMedical Research, Cambridge, MA
5 Washington University, Saint Louis, MO
6 University of Wisconsin, Madison, WI
7 Columbia University, New York, NY
8 Cleveland Clinic Foundation, Cleveland, OH
9 University of Alabama at Birmingham, Birmingham, AL
10 Temple University, Philadelphia, PA
11 Pennsylvania State University, Hershey, PA
12 National Jewish Health, Denver, CO
13 Brigham and Women's Hospital, Division of Rheumatology, Immunology, and Allergy, Boston, MA
539
Le texte complet de cet article est disponible en PDF.Plan
© 2016
Publié par Elsevier Masson SAS.
Vol 139 - N° 2S
P. AB169 - février 2017 Retour au numéro
Article précédent
- Sphingosine Kinase1 Inhibitor SK178 Preferentially Hinders Growth of KIT D816V Mast Cells In Vitro and In Vivo.
- Bandara Geethani, Rosa Munoz-Cano, Avanti Desai, Araceli Tobio, Dean D. Metcalfe, Ana Olivera
- Oxidized Camkii Promotes Asthma through Activating Mast Cells
- Jingjing Qu, Danh C. Do, Yufeng Zhou, Elizabeth D. Luczak, Wayne Mitzner, Mark E. Anderson, Peisong Gao
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?